Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

125.19
+4.283.54%
Volume:10K
Turnover:1.22M
Market Cap:106.41M
PE:- -
High:125.76
Open:123.00
Low:123.00
Close:120.91
52wk High:126.40
52wk Low:54.85
Shares:850.00K
Float Shares:850.00K
Volume Ratio:0.42
T/O Rate:1.15%
Dividend:0.33
Dividend Rate:0.26%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals jumps 7% after rival's drug trial fails to meet key goals

Stock News
·
Aug 10

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-10

Reuters
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS
·
Aug 10

Erasca Appoints Charles Fuchs as President of R&D

Reuters
·
Aug 10

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Reuters
·
Aug 10

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS
·
Aug 10

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Reuters
·
Aug 08

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

TIPRANKS
·
Aug 08

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08